4//SEC Filing
Slichenmyer William 4
Accession 0001181431-12-041050
CIK 0001325879other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:05 PM ET
Size
8.8 KB
Accession
0001181431-12-041050
Insider Transaction Report
Form 4
Slichenmyer William
Chief Medical Officer
Transactions
- Sale
Common Stock
2012-07-17$13.17/sh−2,000$26,333→ 23,693 total - Exercise/Conversion
Common Stock
2012-07-17$9.64/sh+2,000$19,280→ 25,693 total - Exercise/Conversion
Stock Option (right to buy)
2012-07-17−2,000→ 108,500 totalExercise: $9.64Exp: 2019-10-08→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.02 to $13.19, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F3]The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeother
Related Parties
1- filerCIK 0001486428
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:05 PM ET
- Size
- 8.8 KB